In the first three years of the Trump administration, a grand total of 12 letters were sent by the FDA to drug makers warning them over violations found in their clinical drug trials. The agency’s warning letters are sent when the FDA notes violations of practice, procedure, or in some cases, law. In contrast, the first three years of the Obama presidency saw 99 such letters ...
Clinical Drug Trial Inspections Lacking Under Trump Administration
Posted October 31, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls
A new study finds that women are prescribed more medications than men, but are less likely than men to use those medications as prescribed, according to a Washington Post report.
Authors of the study suggest that situation might point to an inherent flaw in the way drugs are tested in the first place. Men tend to be over-represented in early-stage drug trials, so development of medications might not take adequate account of the different way that women’s bodies absorb and metabolize ...
continue reading...
